Patients With Rheumatoid Arthritis (RA) Treated With Rituximab in Kuopio University Hospital

Conditions

• Rheumatoid Arthritis

Eligibility Criteria

Sex

ALL

Age

18 Years - N/A

Healthy Volunteers

Not accepted

Interventions

• rituximab — DRUG
  rituximab two 1000 mg intravenous infusions separated by two weeks
• rituximab, observational study amon patients with active RA — DRUG
  two 1000 mg intravenous infusions separated by 2 weeks

Study Details

One centre follow-up study on safety and efficacy of treatment with rituximab among patients with RA during 4 year period. Basic data is collected for the national register of biologicals.

Key Dates

Start date

Nov 30, 2004

Status verified

Mar 2009

Primary completion

Jul 31, 2008

Completion

Jul 31, 2008

Study Design

Enrollment

49 participants (actual)

Arms

• Arm: patients with active RA
  drug, follow-up

Primary Outcome Measure

ACR20 ACR50 ACR70 response [ Time Frame: 6 and 12 months ]

Related Studies

• CorEvitas Rheumatoid Arthritis (RA) Drug Safety & Effectiveness Registry
  Enrolling By Invitation · CorEvitas · Waltham, Massachusetts
• Physica System Total Knee Replacement Registry Study
  Recruiting · Limacorporate S.p.a · Rancho Mirage, California
• Early Rheumatoid Arthritis Lung Disease Study
  Recruiting · University of Nebraska · Omaha, Nebraska
• Maternal Autoimmune Disease Research Alliance (MADRA) Registry
  Recruiting · Duke University · Durham, North Carolina